Helius Medical Tech (NASDAQ: HSDT)
Q2 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2022-08-11 | ||||||
REV |
Q1 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -1.130 | -1.150 | -0.0200 | ||||
REV | 160.000K | 190.000K | 30.000K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Helius Medical Tech (NASDAQ: HSDT) through any online brokerage.
There are no as such competitors for Helius Medical Tech.
The latest price target for Helius Medical Tech (NASDAQ: HSDT) was reported by Noble Capital Markets on Monday, November 15, 2021. The analyst firm set a price target for 0.00 expecting HSDT to fall to within 12 months (a possible -100.00% downside). 1 analyst firms have reported ratings in the last year.
The stock price for Helius Medical Tech (NASDAQ: HSDT) is $1.27 last updated June 28, 2022, 8:00 PM UTC.
There are no upcoming dividends for Helius Medical Tech.
Helius Medical Tech’s Q2 earnings are confirmed for Thursday, August 11, 2022.
There is no upcoming split for Helius Medical Tech.
Helius Medical Tech is in the Healthcare sector and Medical Devices industry. They are listed on the NASDAQ.